Aim: The aim of this study was to assess the ability of Neuropsychiatric Inventory (NPI) scale profiles to differentiate between distinct frontotemporal dementia (FTD) subtypes. Methods: The NPI was used to assess 311 older patients who had been clinically diagnosed with FTD. FTD subtypes included behavioural variant FTD (bvFTD, n = 121), primary progressive aphasia (semantic variant (n = 69), non-fluent agrammatic variant (n = 31), and logopenic variant (n = 0)), FTD-motor neuron disease (n = 4), progressive supranuclear palsy (n = 43), and corticobasal syndrome (n = 43). Total NPI score and scores for each NPI item were correlated across the distinct FTD subtypes. Results: Patients with bvFTD showed significantly greater impairment on their total NPI score than patients with corticobasal syndrome (P < 0.001), non-fluent agrammatic variant primary progressive aphasia (P < 0.001), progressive supranuclear palsy (P = 0.002), and semantic variant primary progressive aphasia (P = 0.010). Aggressiveness, euphoria, apathy, disinhibition, irritability, aberrant motor behaviours, and appetite disturbance were significantly higher in bvFTD than in the other subgroups. The lowest NPI scores were generally shown among those with CBS. However, NPI total and specific item values overlapped among the subtypes. Conclusions: Patients with bvFTD showed significantly greater neuropsychiatric dysfunction than those with the other FTD subtypes, as measured by the NPI scale. In contrast, patients with corticobasal syndrome had a comparatively healthier profile. Therefore, differential diagnosis among the FTD subtypes may be guided by the NPI, although the subtype is unlikely to be confirmed on the basis of NPI alone.
INTRODUCTION
The distinct clinical subtypes of the broadly defined group of frontotemporal dementia (FTD) syndromes include behavioural variant FTD (bvFTD), FTD with motor neuron disease, language variants or primary progressive aphasias (semantic variant (svPPA), nonfluent agrammatic variant (nfvPPA), and logopenic variant), Steele-Richardson-Olszewski syndrome or progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS). [1] [2] [3] The clinical presentation of bvFTD includes disinhibition, apathy, loss of empathy, eating disorders, and compulsive, perseverative, or stereotyped motor behaviours. 4 The language variants present with semantic anomia (svPPA), effortful and agrammatic speech (nfvPPA), and slow speech with impaired word retrieval (logopenic variant). 5 PSP and CBS symptomatology includes both cognitive and motor features (parkinsonism, down gaze palsy, imbalance (PSP), 6 akinetic parkinsonism, apraxia, and alien hand phenomenon (CBS) 7 ). FTD syndromes are widely regarded as devastating, especially when the age of onset is young. Although the prevalence of FTD is second to Alzheimer's disease in the 40-64 age range, 1, 2, 8 recent epidemiological studies have shown that the prevalence more than doubles among people aged 65 years and over. 3 Therefore, while the overall age-adjusted prevalence of FTD syndromes is 10.8/100 000, that number skyrockets to 42.6/100 000 in the 65-69 subset of the population. Peak prevalence of PSP occurs in the 70-74 age range, and peak prevalence of CBS and nfvPPA occurs in the 75-79 age range. All of this highlights the clear need for clinicians to be vigilant in recognizing FTD subtypes in older populations. 3 Moreover, distinct FTD syndromes differ dramatically in terms of symptom presentation and prognosis, and as such, the importance of early and accurate diagnosis is critical both for the benefit of the patients and for research purposes. The Neuropsychiatric Inventory (NPI) is a wellestablished diagnostic tool that measures behavioural symptoms using 12 distinct subscales. 9 To date, the NPI has mainly been used for distinguishing bvFTD from Alzheimer's disease. 10 The behavioural and neuropsychiatric symptoms of FTD subtypes are not well understood. Only a few studies have measured these symptoms. The majority have not distinguished between different subtypes of FTD, 11, 12 and therefore, they have not described any differences that exist among them. 13, 14 In the present study, we assessed the behavioural and neuropsychiatric symptoms of 311 patients with an FTD syndrome diagnosis. Our aim was to investigate whether distinct FTD subtypes have different NPI scores-either total score or individual item scores-and to assess whether such differences are significant enough to distinguish among the FTD subtypes on an individual patient level.
METHODS
From 1 January 2007 to 31 December 2011, 311 subjects (men: 146; women: 165; mean age: 64 AE 8 years) diagnosed with FTD syndromes according to the international diagnostic criteria were included in this crosssectional study. [2] [3] [4] [5] [6] [7] All subjects were outpatients or inpatients at one of two specialized dementia clinics. The study protocol was in accordance with the ethical standards laid down in the revised Declaration of Helsinki, and ethics approval was granted by the Committee on Human Research of the Medical School of the National and Kapodistrian University of Athens. Research subjects or their legal guardian gave written informed consent. All of the patients underwent an extensive neurologic examination, neuropsychological testing, and brain imaging (magnetic resonance imaging and/or Technetium hexamethylpropyleneamine oxime (99m-HMPAO) single-photon emission computed tomography).
Patients were classified into six distinct diagnostic groups (Table 1) ; and (vi) CBS (n = 43). 7 The NPI questionnaire was completed through caregiver interviews.
We assessed the 12 psychiatric and behavioural domains that are described and screened for by the NPI Total NPI scores and scores for each of the 12 NPI items were entered as outcomes in multivariate linear regression models that included the categorical variable Dx_Code (with values each FTD syndrome) as the main predictor, with adjustments for gender, age, education, handedness, disease duration, and dementia clinic attendance. Associations were considered significant if P < 0.05 and highly significant if P < 0.01. No correction for multiple comparisons was made. To explore differences between bvFTD and each of the other diseases of interest, one set of models included all diseases as values of the categorical variable Dx_Code. Additionally, to explore differences between svPPA and each of the other diseases (except bvFTD), one set of models included all diseases except bvFTD as values of the Dx_Code (Table 2) .
RESULTS
Comparison of total NPI score in bvFTD versus other FTD subtypes Total NPI scores were significantly lower in CBS (P < 0.001), nfvPPA (P < 0.001), PSP (P = 0.002), and svPPA (P = 0.010) than in bvFTD (Fig. 1, Table 2 ).
Comparison of NPI scores by item, using bvFTD as a reference disease Compared with bvFTD patients, CBS patients performed significantly better on the items related to aggressiveness, apathy, eating disturbances, disinhibition, euphoria, and aberrant motor behaviour (P < 0.001). Also, compared with bvFTD patients, nfvPPA patients presented with lower disinhibition scores (P = 0.001), milder and lower rates of aberrant motor behaviours (P = 0.002), and fewer instances of severe sleep disturbances (P = 0.024) and eating disturbances (P = 0.012) ( Table 3) . PSP patients had fewer delusions (P = 0.011); less aggressiveness (P = 0.028), elation (P = 0.012), disinhibition (P = 0.019), and impatience (P = 0.003); and milder aberrant motor behaviours (P = 0.005) than bvFTD patients.
Comparison of NPI item scores in svPPA versus all other FTD subtypes, excluding bvFTD (using svPPA as reference disease) The svPPA group had the second highest total NPI score after the bvFTD group and, consequently, the second most severe neuropsychiatric symptoms. We searched for more subtle differences among the remaining FTD entities (excluding bvFTD). The differences seem to further support the overall impression that CBS is a milder neuropsychiatric disorder among FTD.
CBS patients had significantly better neuropsychologic function as indicated by the overall NPI score (P = 0.003) and by the scores for aggressiveness, apathy, disinhibition, and aberrant motor behaviours (Table 4 ).
In conclusion, the neuropsychiatric function of bvFTD patients, as assessed by the NPI scale, was more severe than that of patients with any other FTD subtype. In contrast, CBS patients appeared to have the least behavioural disturbance of the subtypes examined.
DISCUSSION
Our results showed that bvFTD patients have significantly higher scores for hostile behaviour, apathy, impatience, aberrant motor behaviours, dietary disorders, disinhibition, elation, and total NPI, indicating greater behavioural disturbance among this group.
The CBS subtype distinguished itself on the other end of the scale, with scores reflecting milder dysfunction than bvFTD and svPPA. CBS patients had a lower total NPI score and lower scores on the items for hostile behaviour, apathy, Table 4 Statistically significant differences in total NPI score and the individual NPI items between svPPA and each one of the remaining (except svFTD) FTD subtypes
Comparison with svPPA nfvPPA PSP CBS NPI-TOTAL ** NPI-1 delusions * NPI-2 hallucinations NPI-3 aggressiveness * * * NPI-4 depression NPI-5 anxiety NPI-6 euphoria NPI-7 apathy NPI-8 disinhibition * * * NPI-9 irritability * NPI-10 motor disorders ** NPI-11 sleep disorders NPI-12 appetite disturbance * P < 0.05 but > 0.01, with higher (worse) score in svFTD. ** P < 0.01, with higher (worse) score in svFTD. Model for NPI_TOTAL is shown in Table 2 . Similar models were run for each NPI. CBS, corticobasal degeneration syndromes; FTD, frontotemporal dementia; nfvPPA, non-fluent agrammatic variant primary progressive aphasia; NPI, Neuropsychiatric Inventory; PSP, progressive supranuclear palsy; svFTD, semantic variant or svPPA; svPPA, semantic variant primary progressive aphasia. To our knowledge, no previous study has analyzed patterns of neuropsychiatric and behavioural dysfunction and correlated these measures (both rates and severity) with distinct subtypes of FTD. In doing so, we found that bvFTD patients had severe apathy, euphoria, disinhibition, aberrant motor behaviours, sleep disorders, and dietary disturbances. Previous studies that did not differentiate between FTD subtypes documented similar neuropsychiatric abnormalities among FTD patients as a uniform group. 10, 11 This is not surprising because bvFTD is the most common FTD subtype.
In one small study, 14 neuropsychiatric clinical profiles (total and partial NPI scores) of patients with PSP and other FTD subtypes were found to be similar; the exception was stereotypes and dietary disorders, which were lower in the PSP group. In contrast, in our study, delusions, aggressiveness, euphoria, disinhibition, irritability, and aberrant motor behaviours were found to be less prominent in PSP patients than in bvFTD patients. These divergent findings may be explained by the fact that we specifically compared PSP with bvFTD, whereas the previous study used a more amorphous comparison group. Additionally, the sample size in the present study was larger, allowing for more reliable analysis. Another recent study investigated three distinct FTD syndromes (bvFTD, svPPA, nfvPPA) using the NPI scale and the Frontal Behavioural Inventory scale to assess behavioural and neuropsychiatric disturbances. 13 In agreement with our study, that study found that bvFTD patients had more severe behavioural and neuropsychiatric symptoms than the nfvPPA patients. One limitation of the present study is the lack of autopsy confirmation. There was also no genetic or advanced neuroimaging evidence to support the diagnoses, which were based upon clinical phenotypes of FTD syndromes, with a particular focus upon neuropsychiatric symptoms.
In conclusion, we sought to define the different neuropsychiatric patterns of FTD subtypes as captured by the NPI scale, either as total NPI scores or as item scores. Overall, the total NPI score and many of the different item scores were significantly worse in the bvFTD group than in the svPPA, nfvPPA, PSP, and CBS groups, while they were significantly better in the CBS group than in bvFTD and svPPA groups. However, the behavioural symptomatology overlap among the groups was significant, thus limiting the ability of the NPI scale alone to reliably discriminate among the different FTD subtypes on an individual level. Therefore, a differential diagnosis among the FTD subtypes may be supported by the NPI total and item scores, although it is unlikely to be confirmed on the basis of NPI scale alone.
Early differential diagnosis among FTD syndromes is a significant challenge, the impact of which is felt especially strongly in older patients because the prevalence of FTD increases sharply among them. Given the variability in prognosis observed across FTD subtypes, accurate diagnosis is important. Moreover, an accurate diagnosis, supported by the NPI scale, may contribute to future research by enabling rapid orientation of patients to appropriate clinical trials without unavoidable delays and the cost of genetic or advanced neuroimaging evidence.
